Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms

   
Zaporozhchenko I.A.1 , Bryzgunova O.E.2, Lekchnov E.A.2, Osipov I.D.3, Zaripov M.M.4, Yurchenko Yu.B.1, Yarmoschuk S.V.5, Pashkovskaya O.A.5, Rykova E.Yu.2, Zheravin A.A.5, Laktionov P.P.2

1. Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia
2. Institute of Chemical Biology and Fundamental Medicine SB RAS, Novosibirsk, Russia; Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia
3. Novosibirsk State University, Novosibirsk, Russia
4. FSBIH SDMC of FMBA of Russia, Novosibirsk, Russia
5. Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20186401038      PubMed Id: 29460833
Year: 2018  Volume: 64  Issue: 1  Pages: 38-45
Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesiclesassociated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urine extracellular vesicles and demonstrated diagnostic potential of their miRNA cargo. In this study, we have performed a comparative analysis of the expression of 84 miRNA in paired samples of urine microvesicles and clarified urine from healthy men, patients with benign hyperplasia and cancer of the prostate using miRCURY LNA miRNA qPCR Panels. Subsets of miRNAs with differences in expression between the fractions of the urine were found in all three groups. Two groups of miRNA were identified based on the patterns of their differential expression. They regulate several key signaling pathways associated with prostate cancer development.
Download PDF:  
Keywords: miRNA, exosomes, microvesicles, urine, prostate cancer
Citation:

Zaporozhchenko, I. A., Bryzgunova, O. E., Lekchnov, E. A., Osipov, I. D., Zaripov, M. M., Yurchenko, Yu. B., Yarmoschuk, S. V., Pashkovskaya, O. A., Rykova, E. Yu., Zheravin, A. A., Laktionov, P. P. (2018). Representation analysis of miRNA from clarified urine and urine microvesicles in prostate malignancies and non-malignant neoplasms. Biomeditsinskaya Khimiya, 64(1), 38-45.
This paper is also available as the English translation: 10.1134/S1990750818020142
References  
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)